All articles by
Ultomiris approved in the US for the treatment of adults with neuromyelitis optica spectrum disorder
Ultomiris (ravulizumab-cwvz) has been approved in the United States (US) as the first and only long-acting C5 complement inhibitor for the…
AbbVie`s Elahere gets FDA full approval for platinum-resistant ovarian cancer
AbbVie has received the US Food and Drug Administration`s (FDA) full approval for Elahere (mirvetuximab soravtansine-gynx) to treat certain ovarian…
Rexulti lowers dementia-related neuropsychiatric and agitation symptoms in late-stage trial
Otsuka said that Rexulti (brexpiprazole) has demonstrated its efficacy in two Phase 3 trials involving patients with agitation related to…
FDA expands indications of Esperion’s Nexletol and Nexlizet for heart attacks and LDL-C lowering
The US Food and Drug Administration (FDA) has approved the new label expansions for Esperion Therapeutics’ Nexletol (bempedoic acid) tablets…
Gilead Sciences announces completion of acquisition of CymaBay
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq:…
£1.7m for the world’s first vaccine to prevent lung cancer
Researchers at the University of Oxford, the Francis Crick Institute and University College London have been granted £1.7 million of…